Author:
Nanba Kazutaka,Yahata Kensei,Kikuchi Yuko,Okamoto Chinatsu,Seta Koichi,Sugawara Akira
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference13 articles.
1. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995;13:915–24.
2. Sesoko S, Akema N, Matsukawa T, Kaneko Y. Predisposing factors for the development of malignant essential hypertension. Arch Intern Med. 1987;147:1721–4.
3. Isles CG, Johnson AO, Milne FJ. Slow release nifedipine and atenolol as initial treatment in blacks with malignant hypertension. Br J Clin Pharmacol. 1986;21:377–83.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462–536.
5. Nakamoto H, Nemoto H, Sugahara S, Okada H, Suzuki H. Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up. Hypertens Res. 1999;22:75–80.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献